Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Ismael Lares-Assef"'
Autor:
Carlos Galaviz-Hernández, Blanca P. Lazalde-Ramos, Ismael Lares-Assef, Alejo Macías-Salas, Margarita A. Ortega-Chavez, Héctor Rangel-Villalobos, Martha Sosa-Macías
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
CYP3A5 metabolizes endogenous substrates and ~30% of prescription drugs. The CYP3A5 gene contains an active CYP3A5*1 allele, and a non-functional version, the CYP3A5*3 (rs776746), with consequences for drug therapeutic responses and side effects. Bot
Externí odkaz:
https://doaj.org/article/59a11df9b0394733b7afcec542ad2bfd
Autor:
Jesús Alonso Gándara-Mireles, Ismael Lares-Asseff, Elio Aarón Reyes Espinoza, Verónica Loera Castañeda, Lourdes Patricia Córdova Hurtado, Flor de María Reyes Gutiérrez, Antonio Sandoval-Cabrera, Ignacio Villanueva Fierro, Julio Cesar Grijalva Ávila, Claudia Castro Arreola, Leslie Patrón-Romero, Horacio Almanza Reyes
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
IntroductionL-Asparaginase (L-Asp) is a key drug in the treatment of acute lymphoblastic leukemia (ALL); however, it is commonly associated with the occurrence of adverse events (AE). Risk factors such as age, sex, nutritional status, and some single
Externí odkaz:
https://doaj.org/article/efdad68448de442eb3d12b3bbfe44f4e
Autor:
Liliana Rivera-Espinosa, Eréndira Vicencio-Rosas, Carmen Flores-Pérez, Janett Flores-Pérez, Ismael Lares-Asseff, Jesús Alonso Gándara Mireles, Edelmira Solorio-López, Juan Luis Chávez-Pacheco
Publikováno v:
Dose-Response, Vol 22 (2024)
Background Buprenorphine (BPN) is a widely used analgesic in the pediatric population, although there are few studies on the pharmacokinetics and pharmacodynamics of this drug. Objective The objective was to characterize the pharmacokinetics of BPN a
Externí odkaz:
https://doaj.org/article/f2f2c25076ea4abbb90c44ad885ba6f1
Autor:
Alejo Macías-Salas, Margarita A Ortega-Chavez, Héctor Rangel-Villalobos, Blanca Patricia Lazalde-Ramos, Ismael Lares-Assef, Martha Sosa-Macías, Carlos Galaviz-Hernández
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
CYP3A5 metabolizes endogenous substrates and ~30% of prescription drugs. The CYP3A5 gene contains an active CYP3A5*1 allele, and a non-functional version, the CYP3A5*3 (rs776746), with consequences for drug therapeutic responses and side effects. Bot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::318d62ea569630ae4a1648e84cafc65c
https://www.frontiersin.org/article/10.3389/fphar.2020.00638/full
https://www.frontiersin.org/article/10.3389/fphar.2020.00638/full
Autor:
Carlos, Galaviz-Hernández, Blanca P, Lazalde-Ramos, Ismael, Lares-Assef, Alejo, Macías-Salas, Margarita A, Ortega-Chavez, Héctor, Rangel-Villalobos, Martha, Sosa-Macías
Publikováno v:
Frontiers in Pharmacology
CYP3A5 metabolizes endogenous substrates and ~30% of prescription drugs. The CYP3A5 gene contains an active CYP3A5*1 allele, and a non-functional version, the CYP3A5*3 (rs776746), with consequences for drug therapeutic responses and side effects. Bot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d7a11b291d13efd38d5a3125d0c65213
https://pubmed.ncbi.nlm.nih.gov/32477124
https://pubmed.ncbi.nlm.nih.gov/32477124
Autor:
Saul Flores-Unzueta, Fernando Guerrero-Romero, Ismael Lares-Assef, Laurence A. Marchat, Martha Sosa-Macías, Omar Carrasco-Ortega, Carlos Galaviz-Hernández, Miguel Mauricio Correa-Ramírez
Publikováno v:
Drug Metabolism and Personalized Therapy. 33:153-156
Background Simvastatin is a widely used drug for dyslipidemia treatment, and the best therapeutic effects are achieved at night time. Simvastatin administration has been associated with the development of myopathy. Some polymorphisms in genes that ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c918deaa4418d5f31be3c749b99ee052
https://doi.org/10.1515/dmpt-2018-0016
https://doi.org/10.1515/dmpt-2018-0016
Autor:
Claudia E. Bailón-Soto, Carlos Galaviz-Hernández, Blanca Patricia Lazalde-Ramos, Ismael Lares-Assef, Martha Sosa-Macías, Daniel Hernández-Velázquez, José M. Salas-Pacheco
Publikováno v:
Archives of Medical Research. 45:409-416
High triglyceride levels are closely related to cardiovascular disease. Its development lays on age, diet, physical activity, ethnicity and genetic factors. Among the last, the CYP1A1*2C allele has an influence on the metabolism of cholesterol and ot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db10be44e3809e860bb2e25db3a12a83
https://doi.org/10.1016/j.arcmed.2014.05.007
https://doi.org/10.1016/j.arcmed.2014.05.007
Autor:
Gilberto Castañeda-Hernández, Enrique Teran, María Ana Redal, Marisol López, Jorge E. Morales, Néstor W. Soria, Dante Cáceres, Francisco E Estévez-Carrizo, Idania Rodeiro, Andrés López-Cortés, Miguel Angel Chiurillo, Ismael Lares-Assef, Dinorah Castro de Guerra, José Augusto G. Agúndez, Laura E. Laróvere, Luiz Alexandre V. Magno, Javier Eslava-Schmalbach, Juan P Cayún, Gonzalo Encina, Luis A. Quiñones, Elena García-Martín, Carlos Alberto Isaza, Luisa Herrera, María A Lavanderos, Ángela Roco
Publikováno v:
CURRENT DRUG METABOLISM
Artículos CONICYT
CONICYT Chile
instacron:CONICYT
Artículos CONICYT
CONICYT Chile
instacron:CONICYT
Pharmacogenetics and Pharmacogenomics areas are currently emerging fields focused to manage pharmacotherapy that may prevent undertreatment while avoiding associated drug toxicity in patients. Large international differences in the awareness and in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb6e5d13f67e564be9e845a7956d3d6c
https://doi.org/10.2174/1389200215666140202220753
https://doi.org/10.2174/1389200215666140202220753
Autor:
Aimeé Salas-Hernández, Macarena Galleguillos, Matías Carrasco, Andrés López-Cortés, María Ana Redal, Dora Fonseca-Mendoza, Patricia Esperón, Farith González-Martínez, Ismael Lares-Asseff, Alberto Lazarowski, Verónica Loera-Castañeda, Diadelis Remírez, Matías F. Martínez, Rodrigo Vargas, Fabricio Rios-Santos, Antonio Macho, Juan P. Cayún, Germán R. Perez, Carolina Gutierrez, Leslie C. Cerpa, Tamara Leiva, Susan Calfunao, Lesly Xajil, Christopher Sandoval, Marcelo Suárez, Ariana Gonzalez, Gabriela Echeverría-Garcés, Luis Sullón-Dextre, Eugenia Cordero-García, Alexis R. Morales, Andrea Avendaño, Enrique Sánchez, Laura C. Bastone, Cesar Lara, Patricia Zuluaga-Arias, Ana María Soler, Julio Da Luz, Gabriela Burgueño-Rodríguez, Marcelo Vital, Elizabeth Reyes-Reyes, Alexander Huaccha, Yeimy V. Ariza, Naomi Tzul, Ana L. Rendón, Roberto Serrano, Larissa Acosta, Angelo Motta-Pardo, Leonardo Beltrán-Angarita, Erika Brand, Miguel A. Jiménez, Gladys Maribel Hidalgo-Lozada, Marina M. J. Romero-Prado, Karla Escobar-Castro, Mariel Umaña-Rivas, Juan D. Vivas, Paola Lagos, Yineth Ballén Martínez, Sharleth Quesada, Camila Calfio, Maria L. Arias, María A. Lavanderos, Dante D. Cáceres, Alberto Salazar-Granara, Nelson M. Varela, Luis A. Quiñones
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Pharmacogenomics (PGx) is considered an emergent field in developing countries. Research on PGx in the Latin American and the Caribbean (LAC) region remains scarce, with limited information in some populations. Thus, extrapolations are complicated, e
Externí odkaz:
https://doaj.org/article/cddef7cc0b5d4422b6589bf43ce85f02
Autor:
Andrés López-Cortés, Patricia Esperón, Matías F. Martínez, María A. Redal, Alberto Lazarowski, Nelson M. Varela, Ismael Lares-Asseff, Luis A. Quiñones
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/7c8f53c45e614101a301fed05c339af6